EXHIBIT 31.2

CERTIFICATION

I, Zhang Jian, certify that:

1. I have reviewed this
Quarterly Report on Form 10-Q for the quarter ended September 30, 2009 of China
Biopharmaceuticals Holdings, Inc.;

2. Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with
respect to the period covered by this quarterly report;

3. Based on my knowledge,
the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the
periods presented in this quarterly report;

4. The registrants other
certifying officer(s) and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure
controls and procedures, or caused such disclosure controls or procedures to be
designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
quarterly report is being prepared;

(b) Designed such internal
control over financial reporting, or caused such internal control over
financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles;

(c) Evaluated the
effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation;

(d) Disclosed in this report
any change in the registrants internal control over financial reporting that
occurred during the registrants fourth fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting.

5. The registrants other
certifying officer and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrants auditors and the
audit committee of registrants board of directors (or persons performing the
equivalent function):

(a) all significant
deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report
financial information; and

(b) any fraud, whether or
not material, that involves management or other employees who have a
significant role in the registrants internal control over financial reporting.

| |                                         
| | ----------------------------------------
| | Date: October 29, 2009                  
| |                                         
| | /s/ Zhang Jian                          
| |                                         
| | Zhang Jian                              
| | Chairwoman and Chief
  Financial Officer

---